Wheat gliadin promotes the interleukin-4-induced IgE production by normal human peripheral mononuclear cells through a redox-dependent mechanism

Cytokine

Volumn 21, Issue 6, 2003, Pages 270-280

  Dugas, Bernard ^a,b   Dugas, Nathalie ^c   Conti, Marc ^b   Calenda, Alphonse ^a   Pino, Paco ^b   Thomas, Yolène ^c   Mazier, Dominique ^b   Vouldoukis, Ioannis ^b  

^a Isocell Nutra SAS   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Vigicell Sarl   (France)

Author keywords

Allergy; Gliadin; IgE; Superoxide dismutase; Thiol

Indexed keywords

ACETYLCYSTEINE; GLIADIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 4; SUPEROXIDE DISMUTASE;

ALLERGIC REACTION; ANTIOXIDANT ACTIVITY; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL CULTURE; CHEMOLUMINESCENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; EVALUATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; IMMUNOSTIMULATION; MONONUCLEAR CELL; NORMAL HUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL;

TRITICUM AESTIVUM;

EID: 0038799769     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-4666(03)00100-5     Document Type: Article

References (69)

1. Varjonen E., Vainio E., Kalimo K. Antigliadin IgE - indicator of wheat allergy in atopic dermatitis. Allergy. 55:2000;386-391.
2. Rasanen L., Lehto M., Turjanmaa K., Savoilanen J., Reunala T. Allergy to ingested cereal in atopic children. Allergy. 49:1994;871-876.
3. Bode S., Gudmand-Hoyer E. Symptoms and heamatologic features in consecutive adult coeliac patients. Scand J Gastroenterol. 31:1996;54-60.
4. Song C.H., Vadheim C.M., Snape W.J., Heiner D.C. Antibodies in patients with inflammatory bowel disease and the apparent influence of medications. J Clin Lab Immunol. 46:1995;143-154.
5. Giannotti A., Tiberio G., Castro M., Virgilii F., Colistro F., Ferretti F., et al. Coeliac disease in William syndrome. J Med Genet. 38:2001;767-768.
6. De Vries J.E., Gauchat J.F., Aversa G.G., Punnonen J., Gascan H., Yssel H. Regulation of IgE synthesis. Curr Opin Immunol. 3:1991;351-355.
7. Brown M.A., Pierce J.H., Watson C.J., Falco J., Ihle J.N., Paul W.E. B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell. 50:1987;908-913.
8. Arock M., Merle-Béral H., Dugas B., Ouazz F., Le Goff L., Vouldoukis I., et al. IL-4 release by human leukemic and activated normal basophils. J Immunol. 51:1993;1441-1447.
9. Vercelli D. Regulation of IgE synthesis in humans. J Biol Regul Homeost Agents. 9:1995;1-16.
10. Troncone R., Gianfrani C., Mazzarella G., Greco L., Guardiola J., Auricchio S., et al. Majority of gliadin-specific T-cell clones from coeliac small intestine mucosa produce interferon-gamma and interleukin-4. Dig Dis Sci. 43:1998;156-161.
11. Yukawa K., Kikutani H., Owaki K., Yamasaki K., Yokota A., Nakamura H., et al. A B-cell specific differentiation antigen, CD23, is a receptor for IgE (FcεR) on lymphocytes. J Immunol. 138:1987;2576-2580.
12. Dugas B., Lagente V., Mencia-Huerta J.M., Braquet P. Pharmacological modulation of the expression of the low affinity IgE receptor. Gordon J., Monograph in allergy. vol. 29:1990;76-95 Karger Press, Basel.
13. Suemura M., Kishimoto T. IgE class-specific regulatory factor(s) and Fc epsilon receptors on lymphocytes. Int Rev Immunol. 2:1987;27-42.
14. Vercelli D., Jabara H.H., Lee B.W., Woodland N., Geha R.S., Leung D.Y. Human recombinant interleukin 4 induces FcεR2/CD23 on normal human monocytes. J Exp Med. 167:1988;1406-1416.
15. Pène J., Rousset F., Brière F., Chrétien I., Wideman J., Bonnefoy J.Y., et al. Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cells. The role of soluble CD23 antigen. Eur J Immunol. 18:1988;929-935.
16. Paul-Eugene N., Kolb J.P., Yamaoka K.A., Damais C., Dugas B. Regulatory role of nitric oxide in the IL-4-induced IgE production by normal human peripheral blood mononuclear cells. Lymphokine Cytokine Res. 13:1994;287-293.
17. Paul-Eugene N., Pene J., Bousquet J., Dugas B. Role of cyclic nucleotides and nitric oxide in blood mononuclear cell IgE production stimulated by IL-4. Cytokine. 7:1995;64-69.
18. Dugas N., Dereuddre-Bosquet N., Goujard C., Dormont D., Tardieu M., Delfraissy J.F. Role of nitric oxide in the promoting effect of HIV type 1 infection and of gp120 envelope glycoprotein on interleukin 4-induced IgE production by normal human mononuclear cells. AIDS Res Hum Retroviruses. 10:(16):2000;251-258.
19. Peterson J., Herzenberg L.A., Vasquez K., Waltenbaugh C. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc Natl Acad Sci USA. 95:1998;3071-3076.
20. Benngtsson A., Lundberg M., Avila-Carino J., Jacobsson G., Holmgren A., Scheynius A. Thiols decrease cytokine levels and down-regulate the expression of CD30 on human allergen-specific T helper (Th) 0 and Th2 cells. Clin Exp Immunol. 123:2001;350-360.
21. Pulendran B., Maraskovsky E., Banchereau J., Maliszewski C. Modulating the immune response with dendritic cells and their growth factors. Trends Immunol. 22:2001;41-47.
22. Rutault K., Alderman C., Chain B.M., Katz D.R. Reactive oxygen species activate human peripheral blood dendritic cells. Free Radic Biol Med. 26:1999;232-238.
23. Alderman C.J.J., Shah S., Foreman J.C., Chain B.M., Katz D.R. The role of advanced oxidation protein products in regulation of dendritic cell function. Free Radic Biol Med. 32:2002;377-385.
24. Bachmann M.F., Kopf M. Balancing protective immunity and immunopathology. Curr Opin Immunol. 14:2002;413-419.
25. Ribavene R., Mancini E., Vicenzi M. In vitro cytotoxic effect of wheat gliadin-derived peptides on the Caco-2 intestinal cell line is associated with intracellular oxidative imbalance: implications for coeliac disease. Biochim Biophys Acta. 1453:1999;152-160.
26. Tuckova L., Novotna J., Novak P., Flegelova Z., Kveton T., Jelinkova L., et al. Activation of macrophages by gliadin fragments: isolation and characterization of active peptide. J Leukoc Biol. 71:2002;625-631.
27. Dugas B., Debré P., Moncada S. Nitric oxide: a vital poison inside the immune and inflammatory network. Res Immunol. 146:1995;664-670.
28. Yang Y., Ma J., Song Z., Wu M. HIV-1 TAT-mediated protein transduction and subcellular localization using novel expression vectors. FEBS Lett. 532:2002;36-44.
29. Eum W.S., Choung I.S., Kim A.Y., Lee Y.J., Kang J.H., Park J., et al. Transduction efficacy of Tat-Cu,Zn-superoxide dismutase is enhanced by copper ion recovery of the fusion protein. Mol Cell. 30:2002;334-340.
30. Jin L.H., Bahn J.H., Eum W.S., Kwon H.Y., Jang S.H., Han K.H., et al. Transduction of human catalase mediated by an HIV-1 TAT protein basic domain andarginine-rich peptides into mammalian cells. Free Radic Biol Med. 31:2001;1509-1519.
31. Gross A., Dugas N., Spiesser S., Vouldoukis I., Damais C., Kolb J.P., et al. Nitric oxide production in human macrophagic cells phagocytizing opsonized zymosan: direct characterization by measurement of the luminol dependent chemiluminescence. Free Radic Res. 28:1998;179-191.
32. Dugas B., Renault J.C., Pène J., Bonnefoy J.Y., Petit-Frère C., Braquet P., et al. Interleukin-9 potentiates the interleukin-4 induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol. 23:1993;1687-1692.
33. Paul-Eugène N., Kolb J.P., Calenda A., Gordon J., Kikutani H., Kishimoto T., et al. Functional interaction between β2-adrenoceptor agonists and interleukin-4 in the regulation of IgE-dependent mechanisms in human. Mol Immunol. 30:1993;157-162.
34. Pene J., Rousset F., Brière F., Chretien I., Bonnefoy J.Y., Spits T., et al. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc Natl Acad Sci USA. 85:1988;6880-6884.
35. Stern M., Ciclitira P.J., Van Eckert R., Feighery C., Janssen F.W., Mendez E., et al. Analysis and clinical effect of gluten in coeliac disease. Eur J Gastroenterol Hepatol. 13:2001;741-747.
36. Bonnefoy J.Y., Shields J., Mermod J.J. Inhibition of human IL-4-induced IgE synthesis by a subset of anti-CD23/FcεRII monoclonal antibodies. Eur J Immunol. 20:1990;139-144.
37. Quarsten H., McAdam S.N., Jensen T., Arenz-Hansen H., Molberg O., et al. Staining of coeliac disease-relevant T cells by peptide-DQ2 multimers. J Immunol. 167:2001;4861-4868.
38. Yanagihara Y., Basaki Y., Kajiwara K., Ikizawa K. A thiol antioxidant regulates IgE isotype switching by inhibiting activation of nuclear factor-kappaB. J Allergy Clin Immunol. 100:1997;S33-S38.
39. Michelson A.M., Jadot G., Puget K. Mechanism of anti-inflammatory activity of superoxide dismutase. Hayashi O., Imamura I., Miyachi Y. The biological role of reactive oxygen species in skin. vol. 1:1987;199-210 University of Tokyo Press, Tokyo.
40. Droge W., Breitkreutz R. N-acetyl-cysteine in the therapy of HIV-positive patients. Curr Opin Clin Nutr Metab Care. 2:1999;493-498.
41. Jeannin P., Delneste Y., Lecoanet-Henchoz S., Gauchat J.F., Life P., Holmes D., et al. Thiols decrease human interleukin (IL) 4 production and IL-4-induced immunoglobulin synthesis. J Exp Med. 182:1995;1785-1792.
42. Fawell S., Seery J., Daikh Y., Moore C., Chen L.L., Pepinsky B., et al. Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA. 91:1994;664-668.
43. Jadot G., Vaille A., Maldonado J., Vanelle P. Clinical pharmacokinetics and delivery of superoxide dismutase. Clin Pharmacokinet. 28:1995;17-25.
44. Baret A., Jadot G., Michelson A.M. Pharmacokinetic and anti-inflammatory properties in the rat of superoxide dismutases (Cu SODs and Mn SOD) from various species. Biochem Pharmacol. 17:1984;2755-2760.
45. Nelsen D.A. Jr. Gluten-sensitive enteropathy (celiac disease): more common than you think. Am Fam Physician. 66:2002;2259-2266.
46. Murata Y., Shimamura T., Mauro J. The polarization of T(h)1/T(h)2 balance is dependent on the intracellular thiol redox status of macrophages due to the distinctive cytokine production. Int Immunol. 14:2002;201-212.
47. Kuhlwein E., Irwin M. Melatonin modulation of lymphocyte proliferation and Th1/Th2 cytokine expression. J Neuroimmunol. 117:2001;51-57.
48. Huber M., Baier W., Bessler W.G., Heinevetter L. Modulation of the Th1/Th2 bias by lipopeptide and saponin adjuvants in orally immunized mice. Immunobiology. 205:2002;61-73.
49. Torre P., Fusco S., Quaglia F., La Rotonda M.L., Paparo F., Maglio M., et al. Immune response of the coeliac nasal mucosa to locally-instilled gliadin. Clin Exp Immunol. 127:2002;513-518.
50. Lehto M., Palosuo K., Varjonen E., Majuri M.L., Andersson U., Reunala T., et al. Humoral and cellular responses to gliadin in wheat-dependent, exercise-induced anaphylaxis. Clin Exp Allergy. 33:2003;90-95.
51. Black K.E., Murray J.A., David C.S. HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J Immunol. 169:2002;5595-5600.
52. Knight J.A. Free radicals, antioxidants, and the immune system. Ann Clin Lab Sci. 30:2000;145-158.
53. Dugas N., Lacroix C., Kilchherr E., Delfraissy J.F., Tardieu M. Role of CD23 in astrocytes inflammatory reaction during HIV-1 related encephalitis. Cytokine. 15:2001;96-107.
54. Dugas N., Palacios-Calender M., Dugas B., Riveros-Moreno V., Delfraissy J.F., Kolb J.P., et al. Regulation by endogenous interleukin-10 of the expression of nitric oxide synthase induced after ligation of CD23 in human macrophages. Cytokine. 10:1998;680-689.
55. Paul-Eugene N., Kolb J.P., Sarfati M., Arock M., Ouaaz F., Debre P., et al. Ligation of CD23 activates soluble guanylate cyclase in human monocytes via an L-arginine-dependent mechanism. J Leukoc Biol. 57:1995;160-167.
56. Dugas B., Mossalayi M.D., Damais C., Kolb J.P. Nitric oxide production by human monocytes: evidence for a role of CD23. Immunol Today. 16:1995;574-580.
57. Tuckova L., Novotna J., Novak P., Flegelova Z., Kveton T., Jelinkova L., et al. Activation of macrophages by gliadin fragments: isolation and characterization of active peptide. J Leukoc Biol. 71:2002;625-631.
58. Fridovich I. The biology of superoxide and of superoxide dismutases - in brief. Prog Clin Biol Res. 51:1981;153-172.
59. Melov S. Animal models of oxidative stress, aging, and therapeutic antioxidant interventions. Int J Biochem Cell. 34:2002;1395-1400.
60. Grisham M.B. A radical approach to treating inflammation. Trends Pharmacol Sci. 21:2000;119-120.
61. Halliwell B. Drug antioxidant effects. A basis for drug selection? Drugs. 42:1991;569-605.
62. Yang Y., Ma J., Song Z., Wu M. HIV-1 TAT-mediated protein transduction and subcellular localization using novel expression vectors. FEBS Lett. 532:2002;36-44.
63. Tartour E., Ciree A., Haicheur N., Benchetrit F., Fridman W.H. Development of non-live vectors and procedures (liposomes, pseudo-viral particles, toxin, beads, adjuvantsellipsis) as tools for cancer vaccines. Immunol Lett. 74:2000;45-50.
64. Markey B.A., Phan S.H., Varani J., Ryan U.S., Ward P.A. Inhibition of cytotoxicity by intracellular superoxide dismutase supplementation. Free Radic Biol Med. 9:1990;307-314.
65. Postaire E., Dugas B., Debré P., Gudin C. Immunoregulatory properties of superoxide dismutase. Montagnier L., Olivier R., Pasquier C. Oxidative stress in cancer, AIDS and neurodegenerative diseases. 1998;305-311 Marcel Dekker, Inc, New York.
66. Vouldoukis I., Sivan V., Vozenin M.C., Kamate C., Calenda A., Mazier D., et al. Fc-receptor-mediated intracellular delivery of Cu/Zn-superoxide dismutase (SOD1) protects against redox-induced apoptosis through a nitric oxide dependent mechanism. Mol Med. 6:2000;1042-1053.
67. Dugas B., Pino P., Conti M., Mazier D., Vouldoukis I. Intracellular delivery of bovine Cu/Zn-superoxide dismutase (bSOD1) into human phagocytic cells promotes the expression of natural antioxidant equilibrium through immune-dependent mechanism. Free Radic Biol Med. 33:(Suppl 1):2002;S64. abstract.
68. Postaire E., Dugas B., Calenda A., Sivan V., Lati E., Brack M., et al. Vegetal Cu/Zn-superoxide dismutase protects against HIV-1-induced pro-inflammatory reactions and limit HIV-1 replication and spreading. Free Radic Biol Med. 25:(Suppl 1):1998;S37. abstract.
69. Dugas B. Glisodin®: a nutraceutical product that promote the oral delivery of superoxide dismutase. Free Radic Biol Med. 33:(Suppl 1):2002;S64. abstract.